Dollars for Doctors
How Industry Money Reaches Physicians
ProPublica is tracking the financial ties between doctors and medical companies.
Updated Dollars for Docs
This release includes updated data, payments to teaching hospitals, and information about brand-name prescribing rates for some doctors.
Bill Would Add Nurses, Physician Assistants to Pharma Payments Database
Drugmakers disclose their payments to doctors, dentists, even chiropractors. But spending on nurse practitioners and physician assistants is excluded. Legislation in the Senate would change that.
Transparency Program Obscures Pharma Payments to Nurses, Physician Assistants
New data on drug and device company payments to doctors largely excludes nurse practitioners and physician assistants, though they play an ever-larger role in health care. One advanced-practice nurse pleaded guilty last month to taking drug company kickbacks.
New Dollars for Docs
Pharmaceutical and medical device companies paid billions to doctors from late 2013 through 2014, new data shows. Search for your doctor in our interactive database.
A Pharma Payment A Day Keeps Docs' Finances Okay
New data on payments from drug and device companies to doctors show that many doctors received payments on 100 or more days last year. Some received payments on more days than they didn't.
About the Dollars for Docs Data
Details behind our drug company money database.
Why Pharma Payments to Doctors Were So Hard to Parse
Flaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis.
Vying for Market Share, Companies Heavily Promote 'Me Too' Drugs
Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.
Methodology for Calculating Company Payments to Doctors
Even with new federal data, it's not easy to track drug, device company spending on their products
Dollars for Dudes: Almost No Women Among Medical Industry's Top-Paid Speakers, Consultants
The causes are not clear, but men account for more than 90 percent of the 300 doctors who received the most money from drug and medical device companies, according to new federal data.
$1.1 Billion in Drug, Device Payments to Doctors Not Included in New Federal Database
The new Open Payments database of industry payments to doctors and teaching hospitals is more incomplete than previously known.
Analysis: Government's New Doctor Payments Website Worthy of a Recall
Our health reporter Charles Ornstein takes a test drive using the federal government's new website for drug and device payments. He finds it virtually unusable.
Our First Dive Into the New Open Payments System
The government's data on payments to doctors and hospitals by drug and device makers is incomplete and hard to penetrate – but here's a first look.
What to be Wary of in the Govt's New Site Detailing Industry Money to Docs
The government's new website on drug and device company ties to doctors will be incomplete and may be misleading — for now.
What We've Learned From Four Years of Diving Into Dollars for Docs
Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.
More Data to Be Withheld from Database of Physician Payments
The federal government won’t release data next month on some research payments to doctors. Health officials had acknowledged previously that the database wouldn’t include one-third of payments made by pharmaceutical and medical device companies.
Government Will Withhold One-Third of the Records from Database of Physician Payments
Many payments to doctors made by pharmaceutical and medical device companies will not be included in the public release of the database next month. Federal officials cite data inconsistencies, say records will be posted next June.
Top Acthar Prescribers in Medicare Have Ties to Its Maker
The top four prescribers of the drug were promotional speakers, researchers or consultants.
Glitch Prompts Temporary Shutdown of Pharma Payment Verification System
The government had to take offline its system for doctors to verify payments from drug companies after at least one doctor had payments attributed to him that actually went to someone else.
